Clovibactin and Staphylococcus aureus: a new weapon against resistant strains
2024
Adeiza, Shuaibu Suleiman
Clovibactin is a new depsipeptide and highly efficacious against () , including methicillin-resistant and vancomycin-resistant , with no apparent resistance. Clovibactutclasses current antibiotics such as vancomycin. Here, we discuss its efficacy, emphasize the need for new antibiotics owing to growing global antibiotic resistance, highlight its mode of action and possible benefits over current treatments. We also highlight the challenges involved in large-scale manufacturing and the status of continuing research to advance effective and less toxic derivatives.
显示更多 [+] 显示较少 [-]AGROVOC关键词
书目信息
GMS Hygiene and Infection Control
卷
19
页码
Doc46
ISSN
2196-5226
出版者
German Medical Science GMS Publishing House
其它主题
Eleftheria terrae; Clovibactin
语言
德语
2024-12-11
2024-12-13
DOAJ